Scott Kaatz, DO
Hospitalist · Detroit, MINPI 1376611814
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Johnson & Johnson at 39.5% of the total. Reporting peaked in 2019 at $37,569 and has fallen 89.9% since, to $3,800 in 2025. Among hospitalist clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 190 payments — averaging $766.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$58K
- E.r. Squibb & Sons, L.L.C.$23K
- Pfizer$23K
- AstraZeneca$11K
- Gilead$11K
- Bayer$7K
- plus $13K from 11 others
Across 37 payments — averaging $2605.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$36K
- Stryker$33K
- Janssen Research & Development, LLC$27K
What the payments were for
- Consulting fees$75,64152%
- Speaking & faculty fees$49,65734%
- Grants$1,5001%
- Travel & lodging$11,2818%
- Food & beverage$7,6295%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 62 | $57,529 |
| E.r. Squibb & Sons, L.L.C. | 9 | $23,316 |
| Pfizer | 16 | $22,712 |
| AstraZeneca(2 entities) | 37 | $11,198 |
| Gilead | 15 | $11,181 |
| Bayer | 22 | $7,198 |
| Boston Scientific | 6 | $2,522 |
| Janssen Scientific Affairs, LLC | 3 | $2,113 |
| Portola Pharmaceuticals, LLC | 5 | $1,813 |
| CSL Behring | 1 | $1,560 |
| Novartis | 1 | $1,527 |
| Regeneron | 2 | $1,112 |
| Inari Medical, Inc. | 3 | $1,054 |
| Boehringer Ingelheim | 4 | $343 |
| Abiomed | 2 | $249 |
| Penumbra, Inc. | 1 | $161 |
| Stryker | 1 | $132 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$56,796
- ELIQUIS$25,987
- Veklury$8,616
- ANDEXXA$3,983
- FLOWTRIEVER CATHETER, S$1,564
- Kcentra$1,560
- ENTRESTO$1,527
- GENERAL - STRUCTURAL HEART$1,500
- LOKELMA$1,480
- CT THROMBECTOMY SYSTEM KIT$808
- WATCHMAN Access System$600
- JARDIANCE$231
- Indigo System$161
- Watchman$119
How this compares
$145,720 in reported general payments places this provider in the 95th percentile of 342 hospitalist providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 11 | $86 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Detroit
- Neetu TalrejaDetroit$16K
- Sevan DuffDetroit$2K
- Heba MahmoudDetroit$2K
- Adnan HalboniDetroit$1K
- David PuttDetroit$837
- Anita ChoudharyDetroit$612
- Zakhria BelasherWarren$31K
- Johnathon MarkusClinton Twp$17K
- Cecilia NguyenRoyal Oak$4K
- Dawit WorkuFarmington Hills$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.